SCHEMBL25539059

SCHEMBL25539059

CC1(C)c2cccc(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccc(-c6cccnc6)cc5)n4)c4ccccc34)c2-c2c1ccc1ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.41
PDK2 Q15119 2/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
RAB9A P51151 2/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP19A1 P11511 2/20 0.38
CYP11B1 P15538 2/20 0.38
CYP17A1 P05093 1/20 0.38
CYP11B2 P19099 1/20 0.38
USP1 O94782 7/20 0.37
WDR48 Q8TAF3 7/20 0.37
GPR84 Q9NQS5 1/20 0.36
CYP2C9 P11712 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
HSD17B1 P14061 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25540235 1.00 DHODH (0.41) DHODHPDK2KDM4EALDH1A1RAB9A
SCHEMBL25539056 0.96 GPR84 (0.40) DHODHPDK2KDM4EALDH1A1RAB9A
SCHEMBL25539060 0.95 PDK2 (0.39) DHODHPDK2KDM4EALDH1A1RAB9A
SCHEMBL25540234 0.95 PDK2 (0.39) DHODHPDK2KDM4EALDH1A1RAB9A
SCHEMBL25539934 0.95 DHODH (0.40) DHODHPDK2KDM4EALDH1A1RAB9A
SCHEMBL25536641 0.94 DHODH (0.39) DHODHPDK2KDM4EALDH1A1RAB9A
SCHEMBL25537765 0.94 DHODH (0.39) DHODHPDK2KDM4EALDH1A1RAB9A
SCHEMBL25540084 0.94 DHODH (0.39) DHODHPDK2KDM4EALDH1A1RAB9A
SCHEMBL25540224 0.92 CYP1A1 (0.34) DHODHPDK2KDM4EALDH1A1MAPT
SCHEMBL25538976 0.92 CYP1A1 (0.34) DHODHPDK2KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM DHODH 2394/4885PDK2 1828/4885KDM4E 1565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.